Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis

Antimicrobial Agents and Chemotherapy
Philippe CottagnoudA Stucki

Abstract

The penetration of daptomycin, a new lipopeptide antibiotic, into inflamed meninges ranged between 4.37 and 7.53% (mean, 5.97%). Daptomycin was very efficacious in the treatment of experimental pneumococcal meningitis, producing a decrease of -1.20 +/- 0.32 Deltalog(10) CFU/ml. h in the bacterial titer of Streptococcus pneumoniae against a penicillin-resistant strain and of -0.97 +/- 0.32 Deltalog(10) CFU/ml. h against a penicillin- and quinolone-resistant strain found in cerebrospinal fluid (CSF). For both strains, daptomycin was significantly superior to the standard regimen of a combination of ceftriaxone with vancomycin, sterilizing 9 of 10 CSF samples after 4 h. In vitro, daptomycin produced highly bactericidal activity in concentrations above the MIC.

References

Jun 1, 1990·Antimicrobial Agents and Chemotherapy·P CanepariG Satta
Oct 1, 1974·Antimicrobial Agents and Chemotherapy·R G Dacey, M A Sande
May 1, 1994·Antimicrobial Agents and Chemotherapy·R NauM G Täuber
Oct 10, 1998·Clinical Microbiology Reviews·S L Kaplan, E O Mason
May 29, 1999·The American Journal of Medicine·M R Jacobs
May 17, 2001·Antimicrobial Agents and Chemotherapy·A L BarryS D Brown
Aug 2, 2001·The Journal of Antimicrobial Chemotherapy·A King, I Phillips
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·R WiseG Marshall
Feb 28, 2002·The Journal of Antimicrobial Chemotherapy·Peter C FuchsSteven D Brown
Mar 8, 2002·The New England Journal of Medicine·Ross DavidsonDonald E Low

❮ Previous
Next ❯

Citations

Feb 11, 2011·Current Infectious Disease Reports·Nida Hameed, Allan R Tunkel
Feb 11, 2011·Current Infectious Disease Reports·Uwe KoedelHans-Walter Pfister
Apr 23, 2013·Clinical Pharmacokinetics·Antonello Di PaoloMario Del Tacca
Sep 3, 2013·International Journal of Antimicrobial Agents·Jacques VouillamozGrégory Resch
Nov 29, 2005·Natural Product Reports·Richard H BaltzStephen K Wrigley
Jul 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dong Heun LeeMashiul Chowdhury
Oct 2, 2012·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Rabia SakaryaSelcuk Kara
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·P M Hawkey
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·R E Warren
Apr 8, 2006·Current Opinion in Pediatrics·Denis Grandgirard, Stephen L Leib
Mar 11, 2010·Current Opinion in Infectious Diseases·Uwe KoedelHans-Walter Pfister
Mar 21, 2007·Antimicrobial Agents and Chemotherapy·Denis GrandgirardStephen L Leib
Feb 21, 2008·Antimicrobial Agents and Chemotherapy·Lodewijk Spanjaard, Christina M J E Vandenbroucke-Grauls
Apr 20, 2011·Antimicrobial Agents and Chemotherapy·Ravina KullarMichael J Rybak
Jul 8, 2011·Clinical Microbiology Reviews·Barry B Mook-KanamoriDiederik van de Beek
Oct 18, 2007·Pharmacology·Robert SauermannChristian Joukhadar
May 2, 2009·BMC Infectious Diseases·Barry B Mook-KanamoriRobin Patel
Mar 25, 2008·Therapeutics and Clinical Risk Management·D Matthew ShoemakerWilliam E Roland
Oct 18, 2011·Paediatric Drugs·Shruti Agrawal, Simon Nadel
Jan 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuUNKNOWN Infectious Diseases Society of America
Feb 7, 2008·Expert Review of Anti-infective Therapy·William J PeppardAngela M Urmanski
Oct 28, 2011·Expert Review of Anti-infective Therapy·Bianca WoehrlStephen Leib
Apr 4, 2007·Expert Review of Anti-infective Therapy·Federico Pea, Pierluigi Viale
Apr 4, 2007·Expert Review of Anti-infective Therapy·Zeina A Kanafani, G Ralph Corey
Aug 22, 2015·Expert Review of Anti-infective Therapy·Roland NauHelmut Eiffert
Nov 28, 2007·Expert Review of Anti-infective Therapy·Cindy A Loffler, Conan Macdougall
Oct 3, 2006·Expert Review of Anti-infective Therapy·Edward T Clarke, Robert S Heyderman
Oct 1, 2013·Expert Review of Anti-infective Therapy·Roland NauHelmut Eiffert
Sep 19, 2012·Expert Opinion on Pharmacotherapy·Seon Hee Shin, Kwang Sik Kim
Oct 21, 2014·Expert Opinion on Pharmacotherapy·Ying Ching TanKwang Sik Kim
Oct 7, 2005·Expert Review of Anti-infective Therapy·E David G McIntosh
Jun 30, 2006·Expert Opinion on Pharmacotherapy·Su Young LeeDavid P Nicolau
Jul 25, 2009·Expert Opinion on Emerging Drugs·Ala-Eddine DeghmaneMuhamed-Kheir Taha
Feb 7, 2013·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Jean-François JourdilFrançoise Stanke-Labesque
Nov 17, 2009·Infectious Disease Clinics of North America·Justine Miranda, Allan R Tunkel
May 2, 2009·Enfermedades infecciosas y microbiología clínica·Carlos Pigrau, Benito Almirante
Jun 9, 2009·Médecine et maladies infectieuses·F Van Bambeke, P M Tulkens
May 12, 2009·Médecine et maladies infectieuses·P Chavanet
Apr 27, 2007·International Journal of Antimicrobial Agents·Matthew E FalagasPanayiotis J Papagelopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

© 2021 Meta ULC. All rights reserved